- Home
- DBVT vs CURI Comparison
DBVT vs CURI Comparison
Compare DBVT & CURI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBVT
- CURI
- Stock Information
- Founded
- DBVT 2002
- CURI N/A
- Country
- DBVT France
- CURI United States
- Employees
- DBVT N/A
- CURI N/A
- Industry
- DBVT Biotechnology: Biological Products (No Diagnostic Substances)
- CURI Movies/Entertainment
- Sector
- DBVT Health Care
- CURI Consumer Discretionary
- Exchange
- DBVT Nasdaq
- CURI Nasdaq
- Market Cap
- DBVT 289.8M
- CURI 259.1M
- IPO Year
- DBVT N/A
- CURI N/A
- Fundamental
- Price
- DBVT $9.00
- CURI $4.70
- Analyst Decision
- DBVT Buy
- CURI Strong Buy
- Analyst Count
- DBVT 4
- CURI 2
- Target Price
- DBVT $14.81
- CURI $5.40
- AVG Volume (30 Days)
- DBVT 27.3K
- CURI 517.0K
- Earning Date
- DBVT 07-29-2025
- CURI 08-05-2025
- Dividend Yield
- DBVT N/A
- CURI 6.81%
- EPS Growth
- DBVT N/A
- CURI N/A
- EPS
- DBVT N/A
- CURI N/A
- Revenue
- DBVT $3,800,000.00
- CURI $54,223,000.00
- Revenue This Year
- DBVT $1,743.46
- CURI $24.66
- Revenue Next Year
- DBVT $1,044.34
- CURI $9.72
- P/E Ratio
- DBVT N/A
- CURI N/A
- Revenue Growth
- DBVT N/A
- CURI N/A
- 52 Week Low
- DBVT $2.21
- CURI $0.99
- 52 Week High
- DBVT $12.78
- CURI $7.15
- Technical
- Relative Strength Index (RSI)
- DBVT 44.06
- CURI 48.60
- Support Level
- DBVT $8.51
- CURI $4.45
- Resistance Level
- DBVT $10.93
- CURI $4.92
- Average True Range (ATR)
- DBVT 0.71
- CURI 0.26
- MACD
- DBVT -0.15
- CURI 0.05
- Stochastic Oscillator
- DBVT 20.25
- CURI 63.91
About DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
About CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.